Skip to main content
Clinical Trials/NCT01610258
NCT01610258
Completed
Not Applicable

Contribution of the Study of Maternal Plasmatic Regulator T Cells and Th17 for the Diagnosis of Acute Chorioanmionitis Among Women Hospitalized for Premature Rupture of Fetal Membranes (PPROM) Between 24 and 34 Gestation Weeks

Centre Hospitalier Universitaire Dijon2 sites in 1 country95 target enrollmentMarch 26, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pathology of Pregnancy
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
95
Locations
2
Primary Endpoint
Evaluate the percentage of Treg in maternal blood at the time of admission
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to evaluate if regulator T cells (Treg) and Th17 level modifications in maternal blood and placenta could be correlated to a chorioamnionitis, in women hospitalized for PPROM.

Detailed Description

Acute chorioamnionitis is the principal antecedent of premature birth and an important contributor to specific neonatal and other complications that may extend throughout subsequent life. The PPROM is a high risk condition for developing chorioamnionitis. Available biological markers have a low prognostic value. Indeed, currently the diagnosis of intra-uterine infection relies only on placental cultures and anatomo-pathological exam after the delivery. Moreover, pregnancy is an immunologic particular condition. Indeed an immune tolerance is required with respect to the fetus and is mediated by Treg lymphocytes, which suppressed Th17 activity. Recent studies have shown among women with frequent miscarriages, a balance between Treg and Th17, with a decrease in Treg number and an increase in Th17 number in decidua and blood. In case of infection, the immune pro-inflammatory response (Th17) is restored in peripheric tissues and in blood in order to limit the extention of intra-uterine infection. This restoration of this pro-inflammatory response could be due to a modification of Treg number ou tolerogenic activity. In this context, our hypothesis is that chorioamnionitis will lead to a decrease of treg proportion and an increase of Th17 proportion in lymphocyte populations of maternal blood and placenta, with a back to values near than which is observed in beginning of pregnancy or in no pregnant women.

Registry
clinicaltrials.gov
Start Date
March 26, 2013
End Date
December 8, 2016
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed consent signed
  • Patient affiliated with a social security scheme
  • term pregnancy betwwen 24 and 34 weeks
  • PPROM diagnosis
  • singleton pregnancy

Exclusion Criteria

  • delivery occured in 1 hour after admission
  • hemorragic praevia placenta or retro-placental hematoma
  • confirmed autoimmune or inflammatory disease
  • confirmed infectious disease by VIH, VHC, and VHB

Outcomes

Primary Outcomes

Evaluate the percentage of Treg in maternal blood at the time of admission

Time Frame: the day of delivery or 7 days after the admission if no delivery

Study Sites (2)

Loading locations...

Similar Trials